Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease

Koen C. van Son, Lars Verschuren, Roeland Hanemaaijer, Helen Reeves, R. Bart Takkenberg, Joost P. H. Drenth, Maarten E. Tushuizen, Adriaan G. Holleboom

Research output: Contribution to journalReview articleAcademicpeer-review

4 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) in the setting of non-alcoholic fatty liver disease (NAFLD)-related cirrhosis and even in the pre-cirrhotic state is increasing in incidence. NAFLD-related HCC has a poor clinical outcome as it is often advanced at diagnosis due to late diagnosis and systemic treatment response is poor due to reduced immune surveillance. Much of the focus of molecular research has been on the pathological changes in hepatocytes; however, immune cells, hepatic stellate cells, liver sinusoidal endothelial cells and the extracellular matrix may play important roles in the pathogenesis of NAFLD-related HCC as well. Here, we review the role of non-parenchymal cells in the liver in the pathogenesis of HCC in the context of NAFLD-NASH, with a particular focus on the innate and the adaptive immune system, fibrogenesis and angiogenesis. We review the key roles of macrophages, hepatic stellate cells (HSCs), T cells, natural killer (NK) cells, NKT cells and liver sinusoidal endothelial cells (LSECs) and the role of the extracellular matrix in hepatocarcinogenesis within the steatotic milieu.
Original languageEnglish
Article number1308
JournalCancers
Volume15
Issue number4
DOIs
Publication statusPublished - 1 Feb 2023

Keywords

  • hepatic stellate cells
  • hepatocarcinogenesis
  • hepatocellular carcinoma
  • immune surveillance
  • liver sinusoidal endothelial cells
  • macrophages
  • non-alcoholic fatty liver disease
  • non-alcoholic steatohepatitis
  • non-parenchymal cells

Cite this